sEPO (IU/L) | 患者人数/人 | RBC (×1012/L) | Hb (g/L) | HCT | |||
治疗前 | 治疗后 | 治疗前 | 治疗后 | 治疗前 | 治疗后 | ||
<100 | 18 | 2.48 ± 0.83 | 4.15 ± 1.56* | 58.61 ± 11.8 | 86.22 ± 14.12* | 0.19 ± 0.06 | 0.29 ± 0.06* |
100~200 | 20 | 2.24 ± 0.75 | 3.35 ± 0.79* | 62.9 ± 10.21 | 87.50 ± 16.76* | 0.22 ± 0.05 | 0.31 ± 0.08* |
200~500 | 18 | 2.35 ± 0.78 | 3.26 ± 0.83*# | 64.5 ± 9.64 | 85.67 ± 16.91* | 0.21 ± 0.06 | 0.31 ± 0.07* |
F |
| 0.452 | 3.511 | 1.499 | 0.066 | 1.072 | 0.408 |
P |
| 0.639 | 0.037 | 0.233 | 0.936 | 0.349 | 0.667 |